Inventor
PORTER JOHN ROBERT
GB57 patents
⚠️ This page may combine multiple inventors who share the name “PORTER JOHN ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB BIOPHARMA SPRL
18 patentsUS9873703B2Jan 23, 2018
Imidazopyridazine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations83
US9969728B2May 15, 2018
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL14 citations82
US10775385B2Sep 15, 2020
Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
UCB BIOPHARMA SPRL7 citations81
US9868749B2Jan 16, 2018
Fused imidazole and pyrazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL16 citations81
US9926313B2Mar 27, 2018
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL2 citations71
US9550737B2Jan 24, 2017
TNF -α modulating benzimidazoles
UCB BIOPHARMA SPRL4 citations71
US9475820B2Oct 25, 2016
Substituted imidazo[1,2-a]pyrazines as TNF activity modulators
UCB BIOPHARMA SPRL3 citations70
US9309243B2Apr 12, 2016
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL4 citations68
US10287299B2May 14, 2019
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
UCB BIOPHARMA SPRL1 citations56
US9920052B2Mar 20, 2018
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations52
US9890154B2Feb 13, 2018
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations52
US10093652B2Oct 9, 2018
Tetrahydrobenzimidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9988383B2Jun 5, 2018
Purine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9969729B2May 15, 2018
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9932334B2Apr 3, 2018
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9932342B2Apr 3, 2018
Imidazopyrimidine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9834553B2Dec 5, 2017
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
US9714251B2Jul 25, 2017
Imidazotriazine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
CELLTECH R&D LTD
11 patentsUS6518283B1Feb 11, 2003
Squaric acid derivatives
CELLTECH R&D LTD64 citations96
US6677339B2Jan 13, 2004
Phenylalanine derivatives
CELLTECH R&D LTD19 citations92
US6953798B1Oct 11, 2005
β-alanine derivates
CELLTECH R&D LTD13 citations84
US6911451B1Jun 28, 2005
Phenylalanine derivatives
CELLTECH R&D LTD12 citations84
US6555562B1Apr 29, 2003
Phenylalanine derivatives
CELLTECH R&D LTD13 citations84
US6610700B2Aug 26, 2003
Enamine derivatives
CELLTECH R&D LTD13 citations83
US6534513B1Mar 18, 2003
Phenylalkanoic acid derivatives
CELLTECH R&D LTD11 citations74
US6780874B2Aug 24, 2004
Enamine derivatives
CELLTECH R&D LTD8 citations73
US6521626B1Feb 18, 2003
Thiocarboxamide derivatives
CELLTECH R&D LTD4 citations63
US6455539B2Sep 24, 2002
Squaric acid derivates
CELLTECH R&D LTD4 citations62
US6403608B1Jun 11, 2002
3-Substituted isoquinolin-1-yl derivatives
CELLTECH R&D LTD3 citations62
CELLTECH THERAPEUTICS LTD
9 patentsUS6369229B1Apr 9, 2002
Pyridylalanine derivatives
CELLTECH THERAPEUTICS LTD83 citations98
US6110945AAug 29, 2000
Aromatic amine derivatives
CELLTECH THERAPEUTICS LTD57 citations96
US6362204B1Mar 26, 2002
Phenylalanine derivatives
CELLTECH THERAPEUTICS LTD21 citations92
US6348463B1Feb 19, 2002
Phenylalanine derivatives
CELLTECH THERAPEUTICS LTD28 citations92
US6329372B1Dec 11, 2001
Phenylalanine derivatives
CELLTECH THERAPEUTICS LTD27 citations92
US6197794B1Mar 6, 2001
Phenylalanine derivatives
CELLTECH THERAPEUTICS LTD25 citations92
US6329362B1Dec 11, 2001
Cinnamic acid derivatives
CELLTECH THERAPEUTICS LTD7 citations74
US6274577B1Aug 14, 2001
Benzodiazepines
CELLTECH THERAPEUTICS LTD3 citations63
US6465471B1Oct 15, 2002
Cinnamic acid derivatives
CELLTECH THERAPEUTICS LTD1 citations52
UCB Biopharma SRL
9 patentsUS10705094B2Jul 7, 2020
TNF receptor signaling modulator assay
UCB Biopharma SRL9 citations92
US10883996B2Jan 5, 2021
Methods of identifying signaling modulators of the trimeric TNFa
UCB Biopharma SRL7 citations83
US11022614B2Jun 1, 2021
Antibodies binding to trimeric TNF alpha epitopes
UCB Biopharma SRL5 citations82
US10969393B2Apr 6, 2021
Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
UCB Biopharma SRL5 citations82
US11448655B2Sep 20, 2022
Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors
UCB Biopharma SRL2 citations73
US11174311B2Nov 16, 2021
Antibody against trimeric TNFα complex
UCB Biopharma SRL4 citations72
US12055549B2Aug 6, 2024
Methods of use of anti-TNFα antibodies
UCB Biopharma SRL1 citations71
US11674967B2Jun 13, 2023
Method of identifying potential inhibitors of APO TNFα trimers
UCB Biopharma SRL2 citations71
US12474348B2Nov 18, 2025
Complexes between CD40 and compounds comprising benzimidazole moieties
UCB Biopharma SRL0 citations62
UCB PHARMA SA
2 patentsCELLTECH LTD
1 patentShowing the top 50 of 57 patents by PatentIndex Score.